中性粒细胞/淋巴细胞比值与接受EGFR-TKIs治疗的非小细胞肺癌患者预后关系的Meta分析

doi:10.13481/j.1671-587x.20200625

Abstract

Abstract: Objective

To investigate the effect of neutrophil/lymphocyte ratio （NLR） in judgement of progrosis in the patients with non-small cell lung cancer（NSCLC） after treated with epidermal growth factor receptor tyrosine kinase inhibitors （EGFR-TKIs）， and to provide the evidence-based medical basis for the prognosis judgement of NSCLC patients.

Methods

PubMed， Cochrane Library， EMBASE， Web of Science and China National Knowledge Internet（CNKI） databases were searched for collecting the studies about the relationship between NLR and the prognosis of NSCLC patients treated with EGFR-TKIs. Meta-analysis was conducted on the literatures that met the inclusion criteria.

Results

Eight studies contained 1 451 NSCLC patients were eventually included in the Meta-analysis. The progression-free survival（PFS）［hazard ratio（HR）=1.75， 95% confidence interval（95%CI）：1.24－2.48， Z=3.17， P=0.002］ and overall survival（OS）（HR=1.87， 95%CI：1.21－2.88， Z=2.84， P=0.005） of the NSCLC patients in high NLR group were significantly lower than those in low NLR group. The subgroup analysis results showed that after grouping by the ethnicity and NLR cutoff value， the PFS of NSCLC patients in the Asian（HR=1.70， 95%CI：1.14－2.53， Z=2.62， P=0.009）， the non-Asian（HR=2.00， 95%CI：1.27－3.15， Z=3.00， P=0.003） and the NLR cutoff value≥3.5（HR=2.21， 95%CI：1.54－3.17， Z=4.29， P<0.001） in high NLR group were significantly low than those in low NLR group.The sensitivity analysis results showed that 8 included studies were stable and reliable.

Conclusion

In the NSCLC patients after treated with EGFR-TKIs， the high level of NLR is associated with the poor prognosis of NSCLC patients.

Key words: neutrophil/lymphocyte ratio, cancer，non-small cell lung, prognosis, Meta-analysis

CLC Number:

R734.2

Guangcai WAN,Hongshuai SUN,Hua ZHU,Xiuyan YU. Meta-analysis on relationship between neutrophil/lymphocyte ratio and prognosis of patients with non-small cell lung cancer treated with EGFR-TKIs[J].Journal of Jilin University(Medicine Edition), 2020, 46(6): 1267-1273.

Figures/Tables 6

Fig. 1

Tab. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

References 30

1	GLOBAL BURDEN OF DISEASE CANCER COLLABORATION， FITZMAURICE C， ALLEN C， et al. Global， regional， and national cancer incidence， mortality， years of life lost， years lived with disability， and disability-adjusted life-years for 32 cancer groups， 1990 to 2015： a systematic analysis for the global burden of disease study［J］. JAMA Oncol， 2017， 3（4）： 524-548.
2	SIEGEL R， DESANTIS C， VIRGO K， et al. Cancer treatment and survivorship statistics， 2012［J］. CA Cancer J Clin， 2012， 62（4）： 220-241.
3	孙洪帅，朱华，高海燕，等. 肿瘤标志物SCC-Ag、CEA、CYFRA21-1和D-二聚体联合检测对非小细胞肺癌的早期诊断价值［J］. 吉林大学学报（医学版）， 2018， 44（5）： 1020-1024.
4	周文盛，张伟，韩宝惠. EGFR基因20外显子插入突变在非小细胞肺癌的研究及其进展［J］. 中国肺癌杂志， 2020， 23（2）： 118-126.
5	ZHOU C C， WU Y L， CHEN G Y， et al. BEYOND： a randomized， double-blind， placebo-controlled， multicenter， phase Ⅲ study of first-line carboplatin/paclitaxel plus bevacizumab or placebo in Chinese patients with advanced or recurrent nonsquamous non-small-cell lung cancer［J］. J Clin Oncol， 2015， 33（19）： 2197-2204.
6	NORMANDO S R， CRUZ F M， GIGLIO A D E L. Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancer［J］. Anticancer Drugs， 2015， 26（9）： 995-1003.
7	徐小峰，戴宏宇，乔建兵，等. 外周血NLR和PLR评估晚期非小细胞肺癌一线含铂双药化疗疗效和预后的价值［J］. 现代肿瘤医学， 2020， 28（15）： 2627-2631.
8	LIU J X， LI A， ZHOU L Y， et al. Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer［J］. Future Oncol， 2018， 14（3）： 229-239.
9	CHEN L， ZHANG F， SHENG X G， et al. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and Acts as a superior prognostic factor for cervical cancer when combined with neutrophil： Lymphocyte［J］. Medicine （Baltimore）， 2016， 95（32）： e4381.
10	谢明明. 术前中性粒细胞/淋巴细胞比值在非转移性结肠癌预后中的价值［D］. 福州：福建医科大学，2019.
11	ONO T， IGAWA S， KURAHAYASHI S， et al. Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors［J］. Invest New Drugs， 2020， 38（3）： 885-893.
12	DENG C， ZHANG N， WANG Y P， et al. High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs［J］. Medicine （Baltimore）， 2019， 98（33）： e16875.
13	SIM S H， BEOM S H， AHN Y O， et al. Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors［J］. Thorac Cancer， 2016， 7（2）： 161-166.
14	LIN G N， PENG J W， LIU P P， et al. Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment［J］. Asia Pac J Clin Oncol， 2017， 13（5）： e189-e194.
15	AGUIAR-BUJANDA D， DUEÑAS-COMINO A， SAURA-GRAU S， et al. Neutrophil to lymphocyte ratio as a prognostic factor in European patients with epidermal growth factor receptor-mutant non-small cell lung cancer treated with tyrosine kinase inhibitors［J］. Oncol Res Treat， 2018， 41（12）： 755-761.
16	PHAN T T， HO T T， NGUYEN H T， et al. The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI［J］. Int J Gen Med， 2018， 11： 423-430.
17	MERIGGI F， CODIGNOLA C， BERETTA G D， et al. Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapy［J］. Tumori J， 2017， 103（5）： 443-448.
18	MINAMI S， OGATA Y， IHARA S， et al. Neutrophil-to-lymphocyte ratio predicts overall survival of advanced non-small cell lung cancer harboring mutant epidermal growth factor receptor［J］. World J Oncol， 2017， 8（6）： 180-187.
19	凌丰宇，李明，陈青娟，等. 贝伐珠单抗联合第一代表皮生长因子受体-酪氨酸激酶抑制剂一线治疗EGFR基因突变阳性晚期非小细胞肺癌的Meta分析［J］. 肿瘤， 2020， 40（5）： 339-347.
20	DENARDO D G， COUSSENS L M. Inflammation and breast cancer. Balancing immune response： crosstalk between adaptive and innate immune cells during breast cancer progression［J］. Breast Cancer Res， 2007， 9（4）： 212.
21	HANAHAN D， WEINBERG R A. Hallmarks of cancer： the next generation［J］. Cell， 2011， 144（5）： 646-674.
22	YANG J J， HU Z G， SHI W X， et al. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer： a meta-analysis［J］. World J Gastroenterol， 2015， 21（9）： 2807-2815.
23	DE LARCO J E， WUERTZ B R， FURCHT L T. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8［J］. Clin Cancer Res， 2004， 10（15）： 4895-4900.
24	TURAN N， EDWARDS M J， BATES S， et al. IL-6 pathway upregulation in subgroup of severe asthma is associated with neutrophilia and poor lung function［J］. Clin Exp Allergy， 2018， 48（4）： 475-478.
25	ROTONDO R， BERTOLOTTO M， BARISIONE G， et al. Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation［J］. J Leukoc Biol， 2011， 89（5）： 721-727.
26	BALERMPAS P， RÖDEL F， WEISS C， et al. Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer［J］. Oncoimmunology， 2014， 3（1）： e27403.
27	ZIKOS T A， DONNENBERG A D， LANDRENEAU R J， et al. Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer［J］. Cancer Immunol Immunother， 2011， 60（6）： 819-827.
28	童晶涛，张欢乐，郑璐，等. 血小板和淋巴细胞的比值、中性粒细胞和淋巴细胞的比值与非小细胞肺癌的临床病理学关系及预后效果研究［J］. 中国卫生检验杂志， 2019， 29（24）： 3020-3023.
29	陈浩然，薛昊，刘文静，等. 血小板淋巴细胞比值作为非小细胞肺癌预后因素的meta分析［J］. 中国肺癌杂志， 2019， 22（5）： 289-298.
30	于秀艳，万广财，孙洪帅，等. 纤维蛋白原与乳腺癌患者预后关系的Meta分析［J］. 吉林大学学报（医学版）， 2019， 45（5）： 1092-1097.

First author	Publication year	Ethnicity	Nation	Stage	Duration time	Sample size	Age/(year)	NLR cutoff value	HR value for PFS	95%CI	NOS score
ONO,et al.^[11]	2020	Asia	Japan	Ⅳ	2009－2016	205	Median 70	3.55	1.780	1.290－2.470	9
DENG,et al.^[12]	2019	Asia	China	Ⅳ	2013－2018	203	Median 59	4.40	1.736	1.020－2.954	9
AGUIAR-BUJANDA,et al.^[15]	2018	Non-Asia	Spain	ⅢB-Ⅳ	2010－2016	385	Mean 62.1	4.39	1.668	0.826－3.368	8
PHAN,et al.^[16]	2018	Asia	Vietnam	NR	2015－2018	112	Median 59	2.96	2.150	1.150－3.990	9
MERIGGI,et al.^[17]	2017	Non-Asia	Italy	Ⅳ	2011－2015	63	NR	3.50	2.275	1.257－4.116	8
MINAMI,et al.^[18]	2017	Asia	Japan	ⅢA-B, Ⅳ	2007－2017	152	Mean 70.3	2.11	1.030	0.970－1.100	8
SIM,et al.^[13]	2016	Asia	Korea	ⅢB-Ⅳ	2005－2011	250	Median 64	3.00	1.239	0.693－2.215	8
LIN,et al.^[14]	2014	Asia	China	NR	2009－2012	81	NR	3.50	3.890	1.980－7.680	8

[1]	Ming CHEN,Qinghua LUO,Hongguang JIN,Liang HAN. Atypical lipomatous tumor of left lower limb: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1384-1389.
[2]	Ziru ZHOU,Mengfei SUN,Huakun ZHANG,Shuyan SUN,Qi SUN,Feng LI,Yunzhao CHEN,Jie YU,Yuwen CAO,Xiaobin CUI. Expression of Rh family C glycoprotein in esophageal squamous carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1019-1027.
[3]	Xialing HUANG,Dandan ZHANG,Xuemei ZHANG. Analysis on relationship between methylation of MSX1 gene and clinical pathological features and prognosis of patients with cervical cancer [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 749-756.
[4]	Xiaoyan WANG,Xuelian LI,Bin LIANG,Wenfei TIAN,Hailin MA,Zhijing MO. Analysis on relationship between CALU and prognosis of hepatocellular carcinoma patients and its mechanism based on transcriptome and single cell sequencing data [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 447-459.
[5]	Haiying GENG,Yan YU,Chunmei DAI,Youfeng WEN,Ning LI. Expression of TRIM24 protein in human clear cell renal cell carcinoma tissue and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 486-492.
[6]	Yinxia TAI,Han ZHANG,Lei YU,Xianchun ZHU. Changes in levels of inflammatory factors in gingival crevicular fluid of patients with periodontal disease before and after invisible appliance：A Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 182-190.
[7]	Xi YANG,Qin YUAN,Lan YANG,Wenjie ZHANG. Bioinformatics analysis on PDE1B expression and prognosis of gastric cancer and tumor microenvironment [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1664-1676.
[8]	Jiaxin YI,Yangyu ZHANG,Yingli FU,Yuchen PAN,Yongjie HAN,Jing JIANG,Yanhua WU. Effect of MEIS1 expression on survival in patients after radical gastrectomy and its value in prognostic evaluation [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1358-1364.
[9]	Chaojie GUO,Jiajia ZHANG,Jie ZENG,Huiyu WANG, AIERFATI·Aimaier,Jiang XU. Expressions of PLOD1 in oral squamous cell carcinoma tissue and cells and their significances [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1035-1043.
[10]	Yuanguo WANG,Peng ZHANG. Bioinformatics analysis based on relationship between SSP1 and TGFB1 and occurrence, prognosis, and immune invasion of esophageal adenocarcinoma [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1076-1086.
[11]	Yuan WANG,Zhijuan WANG,Mingshu ZHANG,Yihui WANG,Qing ZHANG,Liping YE. Effects of monocyte chemoattractant protein-1 on invasion and migration of lung cancer A549 and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 666-675.
[12]	Aihua REN,Yanbo DONG,Runzhi MIAO,Yujiao LYU,Yanfeng LIU. Effect of ganoderic acid A on glycolysis and its key rate-limiting enzymes of non-small cell lung cancer PC9 cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 682-688.
[13]	Zongjun CHEN,Yahong CHEN,Liyun HUANG,Ziying LIANG. Effects of genomic instability and MYC gene mutation of non-small cell lung cancer A549 cells on resistance of gemcitabine [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 355-363.
[14]	Yueying SONG,Chao GAO,Wenjun CHEN,Aiyu SHAO,Yichun QIAO,Zhuolin LI. Screening of miRNAs related to prognosis of triple-negative breast cancer and its gene network based on TCGA Database [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 392-399.
[15]	Peng QI,Xianying MENG,Meihua PIAO,Qiang ZHANG. Network Meta-analysis on risk factors of recurrence of papillary thyroid microcarcinoma [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1504-1512.

Meta-analysis on relationship between neutrophil/lymphocyte ratio and prognosis of patients with non-small cell lung cancer treated with EGFR-TKIs

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 30

Related Articles 15

Metrics

Comments

Recommended 10